Absence of the RET+3:T allele in the MTC patients

Pawel Borun1, Sowinski Jerzy, Katarzyna Ziemnicka

  • 1Institute of Human Genetics Polish Academy Sciences, ul, Strzeszyńska 32, 60-479, Poznan, Poland. andp@man.poznan.pl.

Insights

The T allele of RET gene polymorphism rs2435357 was absent in medullary thyroid carcinoma (MTC) patients, unlike the general Polish population. This suggests the T allele may inhibit MTC development.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • The RET proto-oncogene plays a crucial role in medullary thyroid carcinoma (MTC) development, with mutations increasing receptor activity.
  • Polymorphism rs2435357 in the RET gene enhancer, specifically the T variant, has been shown to decrease enhancer activity.

Purpose of the Study:

  • To investigate the frequency of the rs2435357 polymorphism in Polish medullary thyroid carcinoma patients.
  • To explore the potential association between the rs2435357 T allele and the inhibition of MTC development.

Main Methods:

  • A case-control study comparing the frequency of the rs2435357 polymorphism in 48 MTC patients against the general Polish population.
  • Genotyping analysis to determine the allelic and genotypic frequencies of rs2435357.

Main Results:

  • The heterozygous C/T genotype for rs2435357 was observed in nearly 12% of the Polish population (18/152).
  • Notably, not a single T allele was detected in the group of 48 MTC patients.
  • The observed difference in T allele frequency between MTC patients and the general population was statistically significant.

Conclusions:

  • The absence of the T allele in MTC patients suggests a potential protective role.
  • The heterozygous T allele at rs2435357 may be associated with the inhibition of medullary thyroid carcinoma development.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...